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Background: Individuals’ attitudes towards depression and its treatments may influence their 
likelihood of seeking professional help and adherence to treatment when depressed. Objective 
measures, such as the Attitudes Towards Depression and its Treatments scale (ATDT), have 
been developed to assess such attitudes. The aims of this research were to test the reliability and 
validity of ATDT on an Australian sample who were not depressed during the study or who had 
previously been depressed, to explore the attitudes of the Australian public towards depression, 
and to compare these attitudes to those of a Canadian sample of people with depression.
Methods: A sample of 63 males and 140 females (mean age = 32.2 years, SD = 12.9 years) 
from Melbourne, Australia took part in this study. Fourteen of the males and 52 of the female 
participants (mean age = 35.4 years, SD = 13.2 years) stated that they had been previously 
diagnosed with depression.
Results: The attitudes of the Australian sample and the subset of that sample who had  previously 
experienced depression differed from those of the Canadian outpatient sample: they were less 
ashamed of depression, more likely to take antidepressants and consider psychotherapy, and 
more likely to seek help from professionals or significant others in their lives. However, those 
in the Australian sample were more likely to report that antidepressants made them lose control, 
and they were less willing to consider electric shock as a treatment option for their depression. 
The internal reliability as measured by Cronbach’s alpha was lower in the current study (0.63 
and 0.57 for both the general public and the depressed Australian sample) than in the Canadian 
study. Confirmatory factor analysis failed to replicate the factor structure reported previously.
Limitations: The Australian sample of this study may be underrepresentative due to the sam-
pling methods used, and the high proportion of females should not be overlooked.
Conclusion: Researchers should be vigilant when utilizing measures constructed in different 
countries. In comparison to the Canadians, the selected Australian sample had more positive 
attitudes towards depression and its available treatments. The ATDT scale was not a reliable 
and valid measure in this sample.
Keywords: attitudes, depression, objective measures, psychometric properties
Introduction
Depression is a global issue, with consequences that are both economically and socially 
significant.1,2 Research suggests that by the year 2020 depression will be the second 
most important cause of disability worldwide.3 However, around 50% of those with 
major depression do not seek professional help,4–8 and it has been argued that stigma 
is a major contributor to this.9,10 Furthermore, research suggests that personal attitudes, 
such as the belief that health professionals are unsupportive, viewing depression as a 
weakness of character, or the belief that medications are harmful, are also important 
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predictors of avoiding professional help.11,12 In addition, 
patients’ own beliefs about the causes of their depression 
are important in understanding their needs and providing 
effective treatment.13 Research has revealed that belief in bio-
logical causes of depression is correlated with confidence in 
pharmacological treatments and seeking professional help.14 
Conversely, Australian researchers found that those who 
believed that depression is caused by social or environmen-
tal factors (specifically stressors) were more likely to prefer 
self-help and nonpharmacological treatments.15
Beliefs such as stigma, the causes of depression, its 
treatments, and seeking psychological help are important 
factors in understanding attitudes towards depression and its 
treatments. As such, personal attitudes may have a negative 
effect on both initiation and adherence to treatment.16,17 The 
failure to initiate and adhere to treatment may have sub-
stantial consequences such as longer duration of the illness, 
longer lasting psychosocial difficulties, occupational and 
interpersonal impairments and, most importantly, increased 
suicide rates.18,19
In Australia, vignettes are the dominant means of recog-
nizing and identifying depression. Research shows that only 
50% of participants (from a study where N = 900) were able 
to differentiate depression from sadness when presented with 
vignettes.15 The Attitudes Towards Depression and its Treat-
ments scale (ATDT) was developed to address the scarcity of 
objective measures reported in the literature, using a sample 
of 63 Canadian outpatients with nonpsychotic depression.17 
Unlike vignettes, the items included in the ATDT target many 
domains such as causes of depression, available treatments, 
and help-seeking behavior. A group of psychiatrists deter-
mined the appropriateness, clarity, and relevance of the items 
to test attitudes towards depression (88% agreement). The 
internal consistency reliability (Cronbach’s alpha) reported 
for the full-scale ATDT was 0.79. An exploratory factor 
analysis yielded five subscales: acceptance of treatment, 
perceived stigma and shame, negative attitude towards anti-
depressants, self-stigma, and preference for psychotherapy. 
It has been concluded that the ATDT is a reliable and a 
valid measure, and researchers have called for future work 
to replicate and extend these results with larger and more 
heterogeneous samples.17
Therefore, the present study aimed to further test the 
psychometric properties of the ATDT. The attitudes of com-
munity samples are likely to be more relevant to treatment-
seeking than the attitudes in an outpatient sample, so this 
was also examined. Furthermore, the majority of work on 
this topic in Australia has focused on the study of community 
samples where recognition of depression is achieved via 
the presentation of vignettes rather than the utilization of 
 objective measures.20,21
Method
Participants
Sixty-three Australian males and 140 females aged from 
18 to 77 years (M = 32.2, SD = 12.9) participated in the survey. 
Some 48.8% of participants identified themselves as single, 
31.5% were married, 16.7% were in a de facto relationship, 
and 3% were widowed or separated. Their highest education 
level varied, with 1% having completed primary school, 
41.1% secondary school, 16.8% having a diploma, 25.7% an 
undergraduate degree, and 15.3% a postgraduate degree.
Fourteen males and 52 females, with a mean age of 
35.4 years (SD = 13.2), stated that they had been diagnosed 
at some time with depression by a health professional 
 (psychiatrist, psychologist, or general medical  practitioner). 
Of these 66 participants, 62 stated that they either had 
received, or were still receiving, treatment for their depres-
sion, with 24.6% receiving antidepressants, 14.8% receiv-
ing psychotherapy, 57.4% receiving both psychotherapy 
and antidepressants, and 3.3% receiving some other kind 
of treatment. Thirteen individuals (19.7%) stated that they 
had had one episode of depression, nine (13.6%) reported 
two episodes, and 44 (66.7%) reported having had three or 
more episodes.
Measures
Demographics
Information was obtained on participants’ age, sex, ethnic 
background, marital status, education level, previous diagno-
sis of depression, whether there were receiving/had received 
treatment for depression, and the type of treatment.
Attitudes towards depression  
and its treatments scale
Following the advice of A Gabriel (personal communication, 
April 8, 2010), the present study utilized 25 items taken from 
the original 27-item ATDT scale (see Table 1). Two items 
(original item 7, “I feel stigmatized being diagnosed with 
depression”, and original item 17, “People of my culture do 
not allow me to take antidepressants”) were removed and 
the remaining 25 items were numbered sequentially. The 
items were divided into four subscales: patient’s attitude 
to the illness, attitude to biological treatments, attitude to 
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Table 1 Means (standard deviations) for each item on the attitudes towards depression scale for the present sample (n = 203) and the 
sample reported on by Gabriel and Violato17 (n = 63) with the results of t-tests comparing the samples
Item M (SD) t p d
Present Sample Gabriel and Violato
 1. Depression is a legitimate medical disorder 4.2 (1.0) 1.4 (1.0) 20.02 0.001 2.86
 2. I think that depression is a weakness of character 1.9 (1.0) 2.4 (1.6) -2.97 0.003 -0.37
 3. Depression is due to being mentally ill 2.9 (1.1) 3.1 (1.5) -1.15 0.250 -0.15
 4.  I think that depression could be due to a chemical imbalance  
in the brain
3.8 (0.9) 1.7 (1.2) 15.20 0.001 2.00
 5. Depression is just due to feeling sorry for oneself 2.0 (1.0) 2.3 (1.4) -1.88 0.060 -0.25
 6. I cannot tell anyone that I suffer from depression 2.4 (1.1) 2.5 (1.4) -0.59 0.550 -0.08
 7. I am not alone; many others suffer from depression 4.2 (0.8) 1.7 (1.0) 19.69 0.001 2.70
 8. People avoid talking to me because I am depressed 2.3 (1.0) 2.4 (1.4) -0.63 0.530 -0.08
 9. People in the community see me as dangerous 1.7 (0.9) 2.2 (1.7) -2.98 0.003 -0.36
10. I feel less ashamed, since I learned more about the illness 3.3 (1.1) 2.1 (1.3) 7.23 0.001 0.99
11.  I would not take antidepressants as a first line of treatment 2.7 (1.0) 2.7 (1.6) 0.00 1.00 0.00
12. Psychiatric medications are harmful 3.5 (1.3) 2.0 (1.3) 2.66 0.008 0.38
13.  I will consider antidepressants only if my symptoms are  
out of control
3.5 (1.1) 3.5 (1.7) 0.00 1.00 0.00
14. Antidepressants are habit-forming 2.5 (1.0) 2.3 (1.3) 1.32 0.180 0.17
15. Antidepressants make me lose control 3.5 (1.0) 1.9 (1.2) 10.56 0.001 1.45
16.  I will take antidepressants, if my doctor is confident about them 3.6 (1.3) 1.7 (1.0) 10.65 0.001 1.64
17.  I will not accept Electric Shock Treatment for my depression even  
if it is necessary
4.1 (1.0) 3.1 (1.4) 6.26 0.001 0.82
18.  I will consider psychotherapy as a first choice for my depression 3.5 (1.0) 2.8 (1.4) 4.38 0.001 0.57
19. I prefer psychotherapy in combination with my antidepressants 3.5 (1.1) 2.0 (1.1) 9.46 0.001 1.36
20.  I believe that psychotherapy, or “talk therapy”, is always useful  
on its own
2.0 (1.1) 2.6 (1.2) -3.70 0.003 -0.52
21. I prefer to see my family physician if I feel depressed 3.0 (1.1) 4.0 (1.3) -6.02 0.001 -0.83
22. I would ask to see a psychiatrist if I am depressed 3.2 (1.1) 1.8 (1.0) 9.01 0.001 1.33
23. Psychiatrists are not really helpful for depressed persons 2.3 (0.9) 2.0 (1.4) 2.04 0.042 0.26
24. I will seek help from a psychiatrist if I have doubt about medication 3.6 (0.9) 1.7 (1.2) 13.08 0.001 1.76
25.   I would seek help for my depression only from significant others  
in my life
2.5 (1.1) 2.0 (1.3) 3.01 0.002 0.42
psychological treatment, and attitude and perceptions to 
professional help. The items are scored on a 5-point Likert 
scale (from 1 = strongly agree to 5 = strongly disagree). 
Apart from an exploratory factor analysis and assessment of 
internal consistency, little is known about the properties of the 
scale.17 However, replicating the factor structure and internal 
consistency in a different sample was a good first step before 
additional measurement properties were assessed.
Procedure
Following approval by the Royal Melbourne Institute of 
Technology University Ethics Committee, participants were 
recruited via several methods in an attempt to obtain a large 
and more representative sample. Participants were approached 
in community centers and were offered a sealed envelope con-
taining the questionnaires. A snowball sampling technique was 
also utilized by circulating emails about the study. An online 
version of the survey was distributed by the researchers to 
personal and academic contacts who were asked to invite 
others to participate. The study was advertised at a few medi-
cal centers, community churches, advertisement boards at 
the Royal Melbourne Institute of Technology  University, by 
word of mouth, and on the beyondblue National Australian 
Depression Initiative website.22 Participants were asked to 
read a plain language statement and give consent, and had 
the option of completing questionnaires on paper or online. 
Participants were recruited from September 2010 until 
February 2011. While the sample may not be representative, 
the variety of sampling methods employed achieved the 
aim of a larger and more heterogeneous sample.
Results
Table 1 shows the mean and standard deviation of responses 
to each of the 25 items alongside those reported in Canada by 
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Gabriel and Violato.17 Independent samples t-tests revealed 
significant differences between the Australian sample and the 
sample of depressed individuals from Canada for 18 items of 
the ATDT. Items 1, 4, 7, 10, 15, 16, 17, 19, 21, and 24 displayed 
large effect sizes (Cohen’s d . 0.8).23 In general, those in the 
Australian sample had more positive attitudes towards depres-
sion and its treatments than Canadians on items 1, 4, 7, 10, 16, 
19, 21, and 24. However, Australian participants (depressed and 
nondepressed) had more negative attitudes for items 15 and 17, 
in that Australians were more likely to think that antidepres-
sants make them lose control and were less willing to consider 
electric shock as a treatment option for their depression.
As Gabriel and Violato used a sample of individuals with 
depression, comparisons were also made with the subset of 
the present sample that had been diagnosed as depressed. 
A similar pattern of results was found, with significant differ-
ences between the Canadian and the Australian sample with 
depression seen for 18 items (items 1, 4, 7, 10, 16, 18, 19, 21, 
22, and 24 with large effect sizes). Those in the Australian 
subsample had more positive attitudes than Canadians on all 
of these items, except item 21 (Australians were less willing 
to see a family physician when feeling depressed).
Table 2 shows the internal consistency reliability 
 (Cronbach’s alpha) of the total scale and its subscales for 
both the Australian sample and the depressed subsample, 
and for the depressed sample reported in Canada.17 The 
Cronbach’s alpha values for the current study were much 
lower than those reported by Gabriel and Violato: for the 
full sample, the largest value of alpha that was obtained 
was 0.65, and for the depressed subsample, the largest value 
was only 0.57.
The internal consistency analyses indicated that the ATDT 
scale did not share the same factor structure as reported 
by Gabriel and Violato. This was confirmed by the use of 
confirmatory factor analysis using AMOS and maximum like-
lihood estimation. The independence model tests the hypoth-
esis that all variables are unrelated and was easily rejected 
(CMIN = 1296.51; P , 0.001). However, the model proposed 
by Gabriel and Violato was also rejected (CMIN = 776.52; 
P , 0.001, CMIN/df = 2.93). Other fit statistics also provided 
little support for the model (eg, CFI = 0.487, TLI = 0.419, 
RMSEA = 0.098). Consistent with the internal consistency 
analyses, some limited support was found for the ATT sub-
scale where seven of the eight items proposed to load on the 
factor had significant but small regression weights. However, 
support for the other subscales was minimal.
Discussion
The current study revealed significant differences between 
the attitudes of Australians and Canadians towards depression 
and its treatments. This result was unexpected.
The Australian subsample had more positive attitudes 
towards depression than the Canadian sample, in that Australians 
were less ashamed of depression, and were more likely to:
•	 think that depression is a legitimate medical disorder,
•	 think that depression could be due to a chemical imbal-
ance in the brain,
•	 think that many others suffer from depression,
•	 take antidepressants if their doctors are confident about 
them,
•	 consider psychotherapy as the first choice of treatment 
for their depression,
•	 consider a combination of psychotherapy and 
antidepressants,
•	 believe that psychotherapy is always useful on its own,
•	 see a psychiatrist if feeling depressed,
•	 seek help from a psychiatrist if in doubt about medication, 
and
•	 seek help from signif icant others in their life for 
depression.
Conversely, the Australian sample was:
•	 more likely to think that antidepressants make them lose 
control,
•	 less likely to consider electric shock as a treatment option 
even if necessary,
•	 less likely to see a family physician when feeling 
depressed, and
•	 less likely to think that psychiatrists are helpful for a 
depressed person.
Interestingly, the observed differences persisted when 
comparing the two depressed samples – a similar pattern 
Table 2 A comparison of Cronbach’s alpha for the ATDT subscales 
and the total scale for the present sample (n = 203), the subsample 
who reported having received a diagnosis of depression (n = 66) 
and the sample reported on by Gabriel and Violato (n = 63)
Scale Present  
sample 
(n = 203)
Depressed  
subsample 
(n = 66)
Gabriel and  
Violato (2009) 
(n = 63)
ATDat 0.65 0.41 0.76
ATDpss 0.42 0.38 0.76
ATDnaa 0.50 0.49 0.78
ATDss 0.06 0.01 0.64
ATDpp 0.18 0.32 0.58
Total scale 0.63 0.57 0.79
Abbreviations: ATDat, acceptance of treatment; ATDpss,	perceived stigma and 
shame; ATDnaa, negative attitude towards antidepressants; ATDss, self stigma; 
ATDpp, preference for psychotherapy.
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of positive attitudes was seen for the Australian sample, 
although the depressed Australian subsample was less likely 
to see a family physician if feeling depressed.
The reason for the difference in attitudes between the 
two samples is unknown. One would expect that the two 
cultures might be similar. The differences could be due to 
the homogeneity of the Canadian sample, all of whom were 
diagnosed with depression and undergoing treatment at the 
same center. Another possible explanation is the pioneering 
work that has been undertaken in Australia by organizations 
such as beyondblue and the Black Dog Institute to publicize 
and educate the public about depression.24,25 It is also possible 
that the sample of Australians in this study could be biased 
despite the use of multiple sampling strategies.
A reliability analysis revealed that the ATDT is not a 
reliable measure in the present sample. Furthermore, the 
factor structure reported in Canada was not replicated in 
the Australian sample. These findings suggest that new 
measures should be validated before use in different 
countries.
An obvious limitation of this study is the extent to 
which the sample can be representative due to the sam-
pling methods employed. The large sample size, the varied 
sampling methods, and the variability of demographic 
characteristics suggest some degree of representativeness 
of the wider population, unlike the Canadian sample. How-
ever, until replication takes place this remains uncertain 
and any conclusions should be viewed with some caution. 
Furthermore, the high proportion of females should not 
be overlooked.
Without broader replication of the factor structure and 
improvements in the internal consistency of the ATDT, it 
seems premature to assess other psychometric properties such 
as test–retest reliability, precision, and acceptability.
In conclusion, the ATDT was not found to be a reliable 
measure in this Australian sample. However, such measures 
are lacking and more efforts are needed to establish reliable 
and valid tools as they have the potential to assist health pro-
fessionals to select appropriate treatments that are consistent 
with individuals’ attitudes. Furthermore, such tools could 
also be utilized to promptly assess any negative attitudes that 
individuals may hold, allowing health care professionals the 
option of educating patients or modifying their attitudes prior 
to commencing treatment.
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